[89Zr]Zr-ImmunoPET to evaluate the efficacy of cleavable linkers in antibody drug conjugates

被引：0
|
作者：
Garcia, M. Dominguez [1 ]
Raheem, S. J. [1 ]
Sharpe, J. C. [1 ]
Toosi, B. M. [1 ]
Phenix, C. P. [1 ]
Price, E. W. [1 ]
机构：
[1] Univ Saskatchewan, Saskatoon, SK, Canada
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-882
引用
收藏
页码：S283 / S283
页数：1
相关论文
共 50 条
  • [21] 89Zr-ImmunoPET companion diagnostics and their impact in clinical drug development
    McKnight, Brooke N.
    Viola-Villegas, Nerissa T.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2018, 61 (09): : 727 - 738
  • [22] Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma
    Ghai, Anchal
    Zheleznyak, Alexander
    Mixdorf, Matt
    O'Neal, Julie
    Ritchey, Julie
    Rettig, Michael
    DiPersio, John
    Shokeen, Monica
    Achilefu, Samuel
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (05) : 1302 - 1311
  • [23] Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma
    Anchal Ghai
    Alexander Zheleznyak
    Matt Mixdorf
    Julie O’Neal
    Julie Ritchey
    Michael Rettig
    John DiPersio
    Monica Shokeen
    Samuel Achilefu
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1302 - 1311
  • [24] Pressed Solid Target Production of 89Zr and its Application for Antibody Labelling
    Shrivastav, Anjli
    Maurya, Sonu
    Dixit, Manish
    Kumari, Sarita
    Gambhir, Sanjay
    CURRENT RADIOPHARMACEUTICALS, 2024,
  • [25] Exo‐Cleavable Linkers:Antibody Enhancing‐Drug StabilityConjugates and Therapeutic Efficacy in
    Watanabe, Tomohiro
    Fujii, Tomohiro
    Matsuda, Yutaka
    Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry, 2024, 82 (11): : 1117 - 1124
  • [26] Synthesis of [89Zr]Zr-DFO-PEG5-Tz and in vivo evaluation of bioorthogonally labeled antibody
    Lumen, Dave
    Vugts, Danielle
    Lang, Pauline
    Chomet, Marion
    Verlaan, Mariska
    Vos, Ricardo
    Windhorst, Albert
    Airaksinen, Anu
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S483 - S484
  • [27] Preclinical development of [89Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas
    Alvarez, Natalia Herrero
    Lewis, Jason
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S192 - S193
  • [28] Increasing the Tumor-to-Blood Ratio by Click-Cleavable Radioimmunoimaging with [89Zr]Zr-DFO-Trans-Cyclooctene-Trastuzumab in Mice
    de Roode, K. E.
    Vlastara, M.
    Rossin, R.
    Hoeben, F. J. M.
    Boswinkel, M.
    Kleijn, L. H. J.
    Nagarajah, J.
    Heskamp, S.
    Rijpkema, M.
    Robillard, M. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S98 - S98
  • [29] Click-to-Release: Cleavable Radioimmunoimaging with [89Zr]Zr-DFO-Trans-Cyclooctene-Trastuzumab Increases Tumor-to-Blood Ratio
    Vlastara, Maria
    Rossin, Raffaella
    Hoeben, Freek J. M.
    de Roode, Kim E.
    Boswinkel, Milou
    Kleijn, Laurens H. J.
    Nagarajah, James
    Rijpkema, Mark
    Robillard, Marc S.
    THERANOSTICS, 2023, 13 (12): : 4004 - 4015
  • [30] Preclinical evaluation of [89Zr]Zr-ramucirumab: the monoclonal antibody for imaging of VEGFR2 positive tumors
    Novy, Zbynek
    Janousek, Jiri
    Barta, Pavel
    Petrik, Milos
    Hajduch, Marian
    Trejtnar, Frantisek
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S56 - S57
12345